Yuhan Corporation Archives

South Korean Drug for Lung Cancer Gains FDA Approval, Marking Industry Milestone

Yuhan’s Leclaza (lazertinib) (Image provided by Yuhan Corporation) SEOUL, Aug. 23 (Korea Bizwire) – In a significant breakthrough for South Korea’s pharmaceutical industry, Yuhan Corporation’s non-small cell lung cancer treatment has cleared a crucial hurdle with the U.S. Food and Drug Administration (FDA). On August 20, the FDA approved the combination therapy of Yuhan’s [...]

Yuhan Corp. to Be Listed One Tril. Won Club First among Korean Drug Firms

SEOUL, Nov. 5 (Korea Bizwire) – Yuhan Corporation, the first runner in terms of sales and net profit among Korean drug companies, is expected to reach one trillion won sales this year, for the first time as a pharmaceutical company. In a recent electronic disclosure to the Financial Supervisory Service, Yuhan said that its preliminary [...]